Q and A Adjuvant Atezolizumab Plus Bevacizumab Provides “Practice- Changing” Results in HCC
Adjuvant therapy with atezolizumab and bevacizumab improved recurrence-free survival in patients...
Read MoreJul 6, 2023
Adjuvant therapy with atezolizumab and bevacizumab improved recurrence-free survival in patients...
Read MoreJul 5, 2023
An experimental antibody treatment targeting HER2 variants produced powerful results in patients with advanced bile duct cancers, according to findings published in The Lancet Oncology. For a phase 2b clinical trial, James...
Read MoreJul 3, 2023
Sarcopenia occurs often in patients with HCC, according to a large meta-analysis published in Oncology Letters. Researchers examined the prevalence of sarcopenia in patients with HCC in a literature review spanning March 2001 to...
Read MoreJun 30, 2023
Are healthcare professionals entitled to feel as badly as family members when a patient dies? As I...
Read MoreFeb 26, 2023
While clinical guidelines are the norm in medicine these days, most of us recognize they are merely just that—guidance—and can’t eliminate gut instinct. Sometimes, we see a patient and just know there is something not right....
Read More